LINC00930, which was first reported in 2022 to be strongly up-regulated in the nasopharyngeal carcinoma(NPC), positively correlated with tumor stage and grade and associated with lymphatic invasion, metastasis, and poor prognosis [17]. Here, LINC00930 is linked to neoplasm.